Neuroendocrine Health Lab Interpretation 2026 Update Patient-Friendly Elevated urinary 5-HIAA can support an investigation for carcinoid syndrome, but the collection method, laboratory assay and symptom pattern determine what the result actually means. 📖 ~12 minutes 📅 October 10, 2026 📝 Published: October 10, 2026 🩺 Medically Reviewed: October 10, 2026 ✅ Evidence-Based This guide was […]
Complement Testing Lab Interpretation 2026 Update Patient-Friendly Low C1 inhibitor quantity with low function suggests a deficiency; normal or high quantity with low function suggests a dysfunctional protein. Neither pattern alone separates hereditary from acquired angioedema. Tongue or throat swelling needs emergency assessment immediately—not a wait for complement results. 📖 ~12 minutes 📅 October 10, […]
Multiple Sclerosis Lab Interpretation 2026 Update Patient-Friendly A positive result usually reflects JC virus exposure—not PML. The meaningful interpretation combines your antibody result with natalizumab treatment history, previous medicines, symptoms, and MRI surveillance. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically Reviewed: October 9, 2026 ✅ Evidence-Based This guide […]
HTLV-1/2 Lab Interpretation 2026 Update Patient-Friendly A reactive HTLV screening result does not establish infection or mean cancer. Confirmatory antibody testing—and sometimes proviral DNA PCR—clarifies whether infection is present and which virus type needs counseling. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically Reviewed: October 9, 2026 ✅ Evidence-Based […]
Infectious Disease Lab Interpretation 2026 Update Patient-Friendly A positive antibody result can reflect an old immune response rather than living bacteria. Exposure timing, symptoms and the exact laboratory method determine what should happen next. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically Reviewed: October 9, 2026 ✅ Evidence-Based This […]
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly A total phenytoin concentration measures bound and unbound drug together. When protein binding changes, the number on the report may no longer reflect the concentration affecting the brain. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically Reviewed: October 9, 2026 ✅ Evidence-Based […]
Anesthesia Safety Lab Interpretation 2026 Update Patient-Friendly A low dibucaine number can suggest an inherited enzyme variant that prolongs paralysis after succinylcholine or mivacurium. Tell your anesthesiologist before treatment; the result measures enzyme behavior, not how much enzyme activity you have. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically […]
Cystic Fibrosis Lab Interpretation 2026 Update Patient-Friendly A borderline sweat chloride result of 30–59 mmol/L does not confirm cystic fibrosis. It means the result needs follow-up: usually repeat testing at an experienced center, review of symptoms and newborn screening, and sometimes CFTR genetic or functional evaluation. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: […]
Medication Safety Lab Interpretation 2026 Update Patient-Friendly For heart failure, digoxin levels are usually targeted around 0.5–0.9 ng/mL; for atrial fibrillation, current US guidance recommends below 1.2 ng/mL when levels are measured. Samples generally need at least 6–8 hours after a dose. Toxicity can occur within the laboratory interval, especially with kidney impairment, low potassium […]
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly For epilepsy, many laboratories use 3–15 mg/L as a reference interval; bipolar disorder has no established concentration target. Interpret the result alongside dose timing, symptoms, and interacting medicines—not as an instruction to change your dose. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October 8, 2026 🩺 […]